1.	FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DERMATUX, NCT01315990
2.	Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UniHD-2010-11-40-1001, 2010-019748-38, NCT01553032
3.	Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2012-03, NCT01564810
4.	Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: CSET 1542-JANORL2, 2009-017047-34, NCT01211938
5.	Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 9thShanghai, 10DZ1951300, NCT01434394
6.	Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: RTOG 1216, NCI-2013-00500, U10CA021661, NCT01810913
7.	Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 74 Sponsor: NCI, Other Protocol IDs: CDR0000538085, RTOG-0436, NCT00655876
8.	Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000549541, USCTU-4351, USCTU-EPOC, EUDRACT-2006-003121-82, ISRCTN22944367, EU-20732, EPOC, NCT00482222
9.	Phase III Randomized Study of PET/CT Scan-Guided Watchful Waiting Versus Planned Neck Dissection of Locally Advanced Nodal Metastases in Patients Undergoing Chemoradiotherapy For Primary Head and Neck Squamous Cell Carcinoma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WMS-PET-NECK, WMS-PET-NECK, ISRCTN13735240, EU-20856, MREC-07/Q1604/35, UKCRN ID: 3799, NCT00720070
10.	TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: TTCC-2007-01, NCT00716391
11.	S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000649817, S0819, U10CA032102, SWOG-S0819, NCT00946712
12.	Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: RTOG 0920, CDR0000651536, NCT00956007
13.	Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EUDRACT NUMBER 2009-013402-14, NCT00999700
14.	ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20080763, ASPECCT, NCT01001377
15.	Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2007-006254-26, NCT01030042
16.	Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H&N07, NCT01086826
17.	Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: SAKK 75/08, SWS-SAKK-75/08, EUDRACT-2009-016584-10, EU-21024, CDR0000669249, NCT01107639
18.	Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux® Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GORTEC 2009-01, NCT01228565
19.	Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: GORTEC 2007-02, NCT01233843
20.	Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000695731, RTOG-1016, NCT01302834
21.	Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BT-CL-PGG-CRC1031, NCT01309126
22.	Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: CPP-450, 2010-019140-39, NCT01317433
23.	Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 Phase: Phase III Type: Biomarker/Laboratory analysis Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000715505, ECOG-E5397T3, E5397T3, NCT01466244
24.	The Quarterback Trial Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GCO 12-1050, HS 12-00359, IF 1403412, NCT01706939
25.	Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CPP400, 2008-003681-26, NCT01772706